Identifying optimal magnesium replenishment points based on risk of severe hypomagnesemia in colorectal cancer patients treated with cetuximab or panitumumab.

MLA

Kimura, Michio, et al. “Identifying Optimal Magnesium Replenishment Points Based on Risk of Severe Hypomagnesemia in Colorectal Cancer Patients Treated with Cetuximab or Panitumumab.” Cancer Chemotherapy and Pharmacology, vol. 86, no. 3, Sept. 2020, pp. 383–91. EBSCOhost, https://doi.org/10.1007/s00280-020-04126-9.

APA

Kimura, M., Usami, E., Teramachi, H., & Yoshimura, T. (2020). Identifying optimal magnesium replenishment points based on risk of severe hypomagnesemia in colorectal cancer patients treated with cetuximab or panitumumab. Cancer Chemotherapy and Pharmacology, 86(3), 383–391. https://doi.org/10.1007/s00280-020-04126-9

Chicago

Kimura, Michio, Eiseki Usami, Hitomi Teramachi, and Tomoaki Yoshimura. 2020. “Identifying Optimal Magnesium Replenishment Points Based on Risk of Severe Hypomagnesemia in Colorectal Cancer Patients Treated with Cetuximab or Panitumumab.” Cancer Chemotherapy and Pharmacology 86 (3): 383–91. doi:10.1007/s00280-020-04126-9.